A peer-reviewed journal has put out a call for papers to publish in an upcoming special issue on cutting-edge uses of AI in early-phase drug development.
The Journal of Medicinal Chemistry announced its project May 23.
Guest editors for the issue will include Steven Kearnes, PhD, of Google Research, and Jürgen Bajorath, PhD, of the University of Bonn in Germany.
The project leaders say they’ll consider a wide range of methods, applications and novel concepts but will look to emphasize by their choices “how AI approaches are already impacting drug discovery at present rather than how they might add value in the future.”
They’re especially interested in practical applications, case studies and industry-academia collaborations.
The submission period is open already and will remain so through December for articles, briefs and drug annotations. Opinion pieces need to be entered by the end of November.
The issue is slated for publication in June 2020.
For the full submission guidelines, click here.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.